2018 Press Releases

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014

Kindred Biosciences to Present at Cantor Global Healthcare Conference and Ladenburg Thalmann 2018 Healthcare Conference

September 17, 2018

SAN FRANCISCO, Sept. 17, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences to Participate in the B. Riley FBR Annual Healthcare Conference

August 21, 2018

SAN FRANCISCO, Aug. 21, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Second Quarter 2018 Financial Results

August 9, 2018

SAN FRANCISCO, Aug. 9, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Announce Second Quarter 2018 Financial Results

July 16, 2018

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences Announces Commercial Availability of Mirataz® (mirtazapine transdermal ointment) to Veterinarians in the United States

July 9, 2018

SAN FRANCISCO, July 9, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASD... 

Kindred Biosciences Announces Exercise of Option to Purchase Additional Shares and Closing of Public Offering of Common Stock

June 25, 2018

SAN FRANCISCO, June 25, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces the Termination of Its At-The-Market Equity Offering Program

June 20, 2018

SAN FRANCISCO, June 20, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Pricing of Public Offering

June 20, 2018

SAN FRANCISCO, June 20, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Proposed Public Offering of Common Stock

June 19, 2018

SAN FRANCISCO, June 19, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

KindredBio Announces Positive Results from Pilot Effectiveness Study of KIND-014 for the Treatment of Gastric Ulcers in Horses

May 30, 2018

SAN FRANCISCO, May 30, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Present at Jefferies 2018 Global Healthcare Conference and 8th Annual LD Micro Invitational Conference

May 29, 2018

SAN FRANCISCO, May 29, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences to Present at Stifel 2018 Dental & Veterinary Conference

May 24, 2018

SAN FRANCISCO, May 24, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K... 

Kindred Biosciences Announces First Quarter 2018 Financial Results

May 8, 2018

SAN FRANCISCO, May 8, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KI... 

Kindred Biosciences Receives FDA Approval of Mirataz™ (mirtazapine transdermal ointment) for the Management of Weight Loss in Cats

May 7, 2018

SAN FRANCISCO, May 7, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KI... 

Kindred Biosciences Announces the Appointment of Dr. Ernest Mario and Dr. Joseph McCracken to its Board of Directors

April 25, 2018

SAN FRANCISCO, April 25, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences Provides Updates on Pending Drug Approvals

April 24, 2018

SAN FRANCISCO, April 24, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:... 

Kindred Biosciences to Announce First Quarter 2018 Financial Results

April 18, 2018

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences to Present at the Oppenheimer 28th Annual Healthcare Conference

March 8, 2018

SAN FRANCISCO, March 8, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences Announces Fourth Quarter and Full Year 2017 Financial Results

March 1, 2018

SAN FRANCISCO, March 1, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ... 

Kindred Biosciences to Announce Fourth Quarter and Year-End 2017 Financial Results

February 15, 2018

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m... 

Kindred Biosciences to Participate in the Bank of America Merrill Lynch Animal Health Summit

February 13, 2018

SAN FRANCISCO, Feb. 13, 2018 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...